165 related articles for article (PubMed ID: 35436275)
1. Retroperitoneal hematoma in COVID-19 patients - case series.
Elikowski W; Fertała N; Zawodna-Marszałek M; Karoń J; Skrzywanek P; Mozer-Lisewska I; Szczęśniewski P; Łazowski S; Żytkiewicz M
Pol Merkur Lekarski; 2022 Apr; 50(296):118-123. PubMed ID: 35436275
[TBL] [Abstract][Full Text] [Related]
2. The safety and efficacy of use of low-molecular-weight heparin in pediatric neurosurgical patients.
Gonda DD; Fridley J; Ryan SL; Briceño V; Lam SK; Luerssen TG; Jea A
J Neurosurg Pediatr; 2015 Sep; 16(3):329-34. PubMed ID: 26067336
[TBL] [Abstract][Full Text] [Related]
3. Massive retroperitoneal hematoma during enoxaparin treatment of pulmonary embolism after primary total hip arthroplasty: case reports and review of the literature.
Lee MC; Nickisch F; Limbird RS
J Arthroplasty; 2006 Dec; 21(8):1209-14. PubMed ID: 17162185
[TBL] [Abstract][Full Text] [Related]
4. Utilisation and safety of low molecular weight heparins: prospective observational study in medical inpatients.
Cestac P; Bagheri H; Lapeyre-Mestre M; Sié P; Fouladi A; Maupas E; Léger P; Fontan B; Massip P; Montastruc JL
Drug Saf; 2003; 26(3):197-207. PubMed ID: 12580648
[TBL] [Abstract][Full Text] [Related]
5. Hemothorax and retroperitoneal hematoma after anticoagulation with enoxaparin.
Mrug M; Mishra PV; Lusane HC; Cunningham JM; Alpert MA
South Med J; 2002 Aug; 95(8):936-8. PubMed ID: 12190238
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease.
Merli G; Spiro TE; Olsson CG; Abildgaard U; Davidson BL; Eldor A; Elias D; Grigg A; Musset D; Rodgers GM; Trowbridge AA; Yusen RD; Zawilska K;
Ann Intern Med; 2001 Feb; 134(3):191-202. PubMed ID: 11177331
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of Open Surgery for Retroperitoneal Hematoma in Covid-19 Patients: Experience from a Single Centre.
Micic D; Doklestic K; Gregoric P; Ivancevic N; Arsenijevic V; Milin-Lazovic J; Maricic B; Loncar Z
Chirurgia (Bucur); 2022 Oct; 117(5):526-534. PubMed ID: 36318682
[No Abstract] [Full Text] [Related]
8. Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action.
Pavoni V; Gianesello L; Pazzi M; Stera C; Meconi T; Frigieri FC
Thromb Res; 2020 Dec; 196():313-317. PubMed ID: 32977129
[TBL] [Abstract][Full Text] [Related]
9. Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge.
Colwell CW; Collis DK; Paulson R; McCutchen JW; Bigler GT; Lutz S; Hardwick ME
J Bone Joint Surg Am; 1999 Jul; 81(7):932-40. PubMed ID: 10428124
[TBL] [Abstract][Full Text] [Related]
10. Enoxaparin-associated giant retroperitoneal hematoma in pulmonary embolism treatment.
Besir FH; Gul M; Ornek T; Ozer T; Ucan B; Kart L
N Am J Med Sci; 2011 Nov; 3(11):524-6. PubMed ID: 22361501
[TBL] [Abstract][Full Text] [Related]
11. Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.
Prescrire Int; 2013 Apr; 22(137):99-101, 103-4. PubMed ID: 23662321
[TBL] [Abstract][Full Text] [Related]
12. Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial.
; Sadeghipour P; Talasaz AH; Rashidi F; Sharif-Kashani B; Beigmohammadi MT; Farrokhpour M; Sezavar SH; Payandemehr P; Dabbagh A; Moghadam KG; Jamalkhani S; Khalili H; Yadollahzadeh M; Riahi T; Rezaeifar P; Tahamtan O; Matin S; Abedini A; Lookzadeh S; Rahmani H; Zoghi E; Mohammadi K; Sadeghipour P; Abri H; Tabrizi S; Mousavian SM; Shahmirzaei S; Bakhshandeh H; Amin A; Rafiee F; Baghizadeh E; Mohebbi B; Parhizgar SE; Aliannejad R; Eslami V; Kashefizadeh A; Kakavand H; Hosseini SH; Shafaghi S; Ghazi SF; Najafi A; Jimenez D; Gupta A; Madhavan MV; Sethi SS; Parikh SA; Monreal M; Hadavand N; Hajighasemi A; Maleki M; Sadeghian S; Piazza G; Kirtane AJ; Van Tassell BW; Dobesh PP; Stone GW; Lip GYH; Krumholz HM; Goldhaber SZ; Bikdeli B
JAMA; 2021 Apr; 325(16):1620-1630. PubMed ID: 33734299
[TBL] [Abstract][Full Text] [Related]
13. A difficult situation - balancing critical anticoagulation versus the risk of permanent neurologic deficit: a case report.
Cua G; Holland N; Wright A
J Med Case Rep; 2018 Jun; 12(1):180. PubMed ID: 29929554
[TBL] [Abstract][Full Text] [Related]
14. Enoxaparin-associated severe retroperitoneal bleeding and abdominal compartment syndrome: a report of two cases.
Dabney A; Bastani B
Intensive Care Med; 2001 Dec; 27(12):1954-7. PubMed ID: 11797033
[TBL] [Abstract][Full Text] [Related]
15. A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group.
Bergmann JF; Neuhart E
Thromb Haemost; 1996 Oct; 76(4):529-34. PubMed ID: 8902991
[TBL] [Abstract][Full Text] [Related]
16. Early vs. late enoxaparin for the prevention of venous thromboembolism in patients with ICH: A double blind placebo controlled multicenter study.
Qian C; Huhtakangas J; Juvela S; Bode MK; Tatlisumak T; Savolainen M; Numminen H; Ollikainen J; Luostarinen L; Kupila L; Tetri S
Clin Neurol Neurosurg; 2021 Mar; 202():106534. PubMed ID: 33578226
[TBL] [Abstract][Full Text] [Related]
17. Bilateral Femoral Neuropathy Following Psoas Muscle Hematomas Caused by Enoxaparin Therapy.
Macauley P; Soni P; Akkad I; Demir S; Shankar S; Kakar P; Bhardwaj S
Am J Case Rep; 2017 Aug; 18():937-940. PubMed ID: 28848224
[TBL] [Abstract][Full Text] [Related]
18. Renal failure and low molecular weight heparins. A dangerous liaison? The case of retroperitoneal hematoma.
Kravitz MS; Mishaal RA; Shoenfeld Y
Isr Med Assoc J; 2005 Sep; 7(9):600-1. PubMed ID: 16190487
[No Abstract] [Full Text] [Related]
19. Safety of low-dose subcutaneous enoxaparin for the prevention of venous thromboembolism after primary intracerebral haemorrhage.
Tetri S; Hakala J; Juvela S; Saloheimo P; Pyhtinen J; Rusanen H; Savolainen ER; Hillbom M
Thromb Res; 2008; 123(2):206-12. PubMed ID: 18420258
[TBL] [Abstract][Full Text] [Related]
20. Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol.
Jaffer AK; Ahmed M; Brotman DJ; Bragg L; Seshadri N; Qadeer MA; Klein A
J Thromb Thrombolysis; 2005 Aug; 20(1):11-6. PubMed ID: 16133889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
